Golimumab, a human antibody to tumour necrosis factor α given by monthly subcutaneous injections, in active rheumatoid arthritis despite methotrexate therapy: the GO-FORWARD StudyEdward Keystone, Mahboob U. Rahman, J Pazdur et al.|Annals of the Rheumatic Diseases|2008Cited by 540
STC2 Is a Potential Prognostic Biomarker for Pancreatic Cancer and Promotes Migration and Invasion by Inducing Epithelial–Mesenchymal TransitionLin Chen, Zhixian Wu|BioMed Research International|2019Cited by 33